SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-11-002525
Filing Date
2011-05-13
Accepted
2011-05-13 14:33:31
Documents
5
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0311_soligenix.htm 10-Q 592653
2 CERTIFICATIONS PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT OF 2002 f10q0311ex31i_soligenix.htm EX-31.1 14715
3 CERTIFICATIONS PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT OF 2002 f10q0311ex31ii_soligenix.htm EX-31.2 14278
4 CERTIFICATIONS PURSUANT TO SECTION 906 OF SARBANES OXLEY ACT OF 2002 f10q0311ex32i_soligenix.htm EX-32.1 6553
5 CERTIFICATIONS PURSUANT TO SECTION 906 OF SARBANES OXLEY ACT OF 2002 f10q0311ex32ii_soligenix.htm EX-32.2 6221
  Complete submission text file 0001213900-11-002525.txt   635708
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 11839993
SIC: 2834 Pharmaceutical Preparations